United Asset Strategies, Inc. Pfizer Inc Transaction History

United Asset Strategies, Inc.

$1.07 Billion
Q3 2024

A detailed history of United Asset Strategies, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, United Asset Strategies, Inc. holds 32,274 shares of PFE stock, worth $862,361. This represents 0.09% of its overall portfolio holdings.

Number of Shares

32,274

Previous 30,133 7.11%

Holding current value

$862,361

Previous $843,000 10.79%

% of portfolio

0.09%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$27.7 - $31.39 $59,305 - $67,205	2,141 Added 7.11%	32,274 $934,000
Q2 2024 Aug 01, 2024	SELL	$25.26 - $29.6 $4,420 - $5,180	-175 Reduced 0.58%	30,133 $843,000
Q1 2024 Apr 23, 2024	SELL	$25.89 - $29.73 $468,531 - $538,023	-18,097 Reduced 37.39%	30,308 $841,000
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $409,744 - $532,213	-15,681 Reduced 24.47%	48,405 $1.39 Million
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $1.25 Million - $1.46 Million	-38,950 Reduced 37.8%	64,086 $2.13 Million
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $179,119 - $207,236	4,959 Added 5.06%	103,036 $3.78 Million
Q1 2023 Apr 25, 2023	BUY	$39.39 - $51.28 $228,028 - $296,859	5,789 Added 6.27%	98,077 $4 Million
Q4 2022 Jan 26, 2023	BUY	$41.75 - $54.5 $288,075 - $376,050	6,900 Added 8.08%	92,288 $0
Q3 2022 Oct 24, 2022	BUY	$43.76 - $53.42 $206,240 - $251,768	4,713 Added 5.84%	85,388 $3.74 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $178,861 - $212,073	3,844 Added 5.0%	80,675 $4.23 Million
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $2.63 Million - $3.26 Million	-57,459 Reduced 42.79%	76,831 $3.98 Million
Q4 2021 Jan 31, 2022	SELL	$41.32 - $61.25 $75,822 - $112,393	-1,835 Reduced 1.35%	134,290 $7.93 Million
Q3 2021 Oct 21, 2021	SELL	$39.25 - $50.42 $35,521 - $45,630	-905 Reduced 0.66%	136,125 $5.86 Million
Q2 2021 Jul 19, 2021	BUY	$35.91 - $40.68 $200,270 - $226,872	5,577 Added 4.24%	137,030 $5.37 Million
Q1 2021 Apr 27, 2021	SELL	$33.49 - $37.77 $80,677 - $90,987	-2,409 Reduced 1.8%	131,453 $4.76 Million
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $1.08 Million - $1.38 Million	32,325 Added 31.84%	133,862 $4.93 Million
Q3 2020 Nov 03, 2020	BUY	$31.75 - $37.25 $1.19 Million - $1.4 Million	37,576 Added 58.75%	101,537 $3.73 Million
Q2 2020 Aug 03, 2020	BUY	$30.12 - $36.54 $172,828 - $209,666	5,738 Added 9.86%	63,961 $2.09 Million
Q1 2020 May 08, 2020	SELL	$27.03 - $38.62 $51,708 - $73,880	-1,913 Reduced 3.18%	58,223 $1.9 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $33,808 - $38,368	1,027 Added 1.74%	60,136 $2.36 Million
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $1.41 Million - $1.82 Million	-43,257 Reduced 42.26%	59,109 $2.12 Million
Q2 2019 Jul 31, 2019	BUY	$36.98 - $41.52 $491,168 - $551,468	13,282 Added 14.91%	102,366 $4.44 Million
Q1 2019 May 02, 2019	BUY	$37.5 - $41.2 $1.02 Million - $1.12 Million	27,112 Added 43.75%	89,084 $3.78 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $114,063 - $130,044	-2,965 Reduced 4.57%	61,972 $2.71 Million
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $33,987 - $41,224	-986 Reduced 1.5%	64,937 $2.86 Million
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $199,561 - $212,753	-6,051 Reduced 8.41%	65,923 $2.39 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $26,006 - $30,171	-815 Reduced 1.12%	71,974 $2.55 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $4,623 - $4,905	-139 Reduced 0.19%	72,789 $2.64 Million
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $2.26 Million - $2.49 Million	72,928	72,928 $2.6 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Asset Strategies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on United Asset Strategies, Inc. with notifications on news.

Account

United Asset Strategies, Inc. Pfizer Inc Transaction History